Adam Lauring, MD, PhD
Professor of Internal Medicine
Professor of Microbiology and Immunology
Professor of Ecology and Evolutionary Biology
College of Literature, Science, and the Arts
[email protected]

Available to mentor
Adam Lauring, MD, PhD
Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    Dr. Lauring is a physician-scientist with a research interest in the genetics and evolution of RNA viruses

    Links
    • Lauring Lab
    Qualifications
    • MD
      University of Washington, Seattle, 2002
    • PhD
      University of Washington, Seattle, 2000
    • BS
      Yale University, New Haven, 1994
    Research Overview

    Dr. Lauring’s laboratory has worked in three main areas. First, they study the importance of mutation rate and mutational tolerance to the evolution of poliovirus and influenza virus. More recently, they have utilized next generation sequencing of patient samples to define the within-host evolution and transmission of influenza virus, poliovirus, and SARS-CoV-2. Since the beginning of the COVID pandemic, his laboratory has collaborated with large teams to study the genomic epidemiology of respiratory viruses and the effectiveness of vaccines against them.

    Recent Publications See All Publications
    • Journal Article
      Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
      Feldstein LR, Ruffin J, Wiegand RE, Borkowf CB, James-Gist J, Babu TM, Briggs-Hagen M, Chappell J, Chu HY, Englund JA, Kuntz JL, Lauring AS, Lo N, Carone M, Lockwood C, Martin ET, Midgley CM, Monto AS, Naleway AL, Ogilvie T, Saydah S, Schmidt MA, Schmitz JE, Smith N, Sohn I, Starita L, Talbot HK, Weil AA, Grijalva CG. J Infect Dis, 2025 Jan 8; DOI:10.1093/infdis/jiaf007
      PMID: 39774936
    • Journal Article
      Virus Evolution in Prolonged Infections of Immunocompromised Individuals.
      Raglow Z, Lauring AS. Clin Chem, 2025 Jan 3; 71 (1): 109 - 118. DOI:10.1093/clinchem/hvae150
      PMID: 39749520
    • Journal Article
      Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
      Lewis NM, Harker EJ, Leis A, Zhu Y, Talbot HK, Grijalva CG, Halasa N, Chappell JD, Johnson CA, Rice TW, Casey JD, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, DeCuir J, Surie D, Dawood FS, Ellington S, Self WH, Martin ET. Vaccine, 2025 Jan 1; 43 (Pt 2): 126492 DOI:10.1016/j.vaccine.2024.126492
      PMID: 39515195
    • Journal Article
      Maternal-Infant Respiratory Syncytial Virus and Influenza A Virus Antibody Transfer in Preterm and Full-term Infants.
      Rumfelt KE, Pike M, Stolarczuk JE, Lekander A, Lauring AS, Eckert LO, Englund JA, Martin ET, Kachikis AB. Open Forum Infect Dis, 2025 Jan; 12 (1): ofae723 DOI:10.1093/ofid/ofae723
      PMID: 39758746
    • Journal Article
      Protection from COVID-19 vaccination and prior SARS-CoV-2 infection among children aged 6 months - 4 years, United States, September 2022-April 2023.
      Feldstein LR, Ruffin J, Wiegand R, Grant L, Babu TM, Briggs-Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Kuntz J, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Naleway AL, Newes-Adeyi G, Odame-Bamfo L, Olsho LE, Phillips AL, Rai RP, Saydah S, Smith N, Tyner H, Vaughan M, Weil AA, Yoon SK, Britton A, Gaglani M. J Pediatric Infect Dis Soc, 2024 Dec 5; DOI:10.1093/jpids/piae121
      PMID: 39656907
    • Journal Article
      Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel.
      Fowlkes AL, Peretz A, Greenberg D, Hirsch A, Martin ET, Levine MZ, Edwards L, Radke S, Lauring AS, Ferdinands JM, Zhang C, Yoo YM, Dreiher J, Newes-Adeyi G, Azziz-Baumgartner E, Fry AM, Monto AS, Balicer R, Thompson MG, Katz MA. Int J Infect Dis, 2024 Dec; 149: 107260 DOI:10.1016/j.ijid.2024.107260
      PMID: 39395753
    • Journal Article
      Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study.
      Lewis NM, Harker EJ, Grant LB, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Busse LW, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Hough CL, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Martinez A, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Goyal A, DeLamielleure LE, DeCuir J, Surie D, Dawood FS, Tenforde MW, Uyeki TM, Garg S, Ellington S, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . Clin Infect Dis, 2024 Nov 28; DOI:10.1093/cid/ciae584
      PMID: 39607747
    • Preprint
      In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants.
      Bendall EE, Dimcheff D, Papalambros L, Fitzsimmons WJ, Zhu Y, Schmitz J, Halasa N, Chappell J, Martin ET, Biddle JE, Smith-Jeffcoat SE, Rolfes MA, Mellis A, Talbot HK, Grijalva C, Lauring AS. 2024 Nov 22; DOI:10.1101/2024.11.21.624722
      PMID: 39605326
    Featured News & Stories pigs sick and chickens in background with blue background and green cells floating around
    Health Lab
    Why the bird flu’s jump to pigs is concerning
    A Michigan Medicine virologist speaks about the implications of H5N1 influenza, or bird flu, and whether a new pandemic could be on the horizon.
    News Release
    Building a COMPASS to navigate future pandemics
    An $18 million National Science Foundation grant will establish a new center to bring computer science, infectious disease, engineering, and the arts together to predict and prevent global pandemics
         Microscopic rendering of the flu virus with green, purple and red coloring
    News Release
    $10 million NIH-award establishes new U-M center to study genomics of infectious disease pathogens
    A new NIH award will establish the Michigan Infectious Disease Genomics (MIDGE) Center, the goal of which is to use whole genome sequencing and functional genomic assays to determine how genetic differences among strains or isolates affect the behavior, transmission, and drug resistance of viral, bacterial, and fungal pathogens.
         Q&A with trainees at MMMP scientific symposium, June 18, 2024
    Department News
    MMMP celebrates 25 years of its NIH T32 training grant
    The Department of Microbiology and Immunology (M&I) celebrated 25 years of its NIH T32 training grant that supports the Molecular Mechanisms in Microbial Pathogenesis Training Program (MMMP) with a scientific symposium, held June 18, 2024.
         Lab of Erin M. Janssen, M.D., Ph.D.
    Medical School News
    Labs go platinum: Research teams record efforts to achieve sustainability certification
    Many Michigan Medicine labs are taking time to ensure that they are doing their part to support the Medical School’s major initiatives, including the push for carbon neutrality.